Yosuke Aihara
Overview
Explore the profile of Yosuke Aihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Namisaki T, Moriya K, Noguchi R, Kitade M, Kawaratani H, Yamao J, et al.
Hepatol Res
. 2016 May;
47(3):E178-E186.
PMID: 27189879
No abstract available.
12.
Nishimura N, Kitade M, Noguchi R, Namisaki T, Moriya K, Takeda K, et al.
J Gastroenterol
. 2016 Mar;
51(12):1141-1149.
PMID: 27025708
Background: It is widely understood that insulin resistance (IR) critically correlates with the development of liver fibrosis in several types of chronic liver injuries. Several experiments have proved that anti-IR...
13.
Namisaki T, Noguchi R, Moriya K, Kitade M, Aihara Y, Douhara A, et al.
J Gastroenterol
. 2015 Jul;
51(2):162-72.
PMID: 26190501
Background And Aims: Ursodeoxycholic acid (UDCA) is considered to be effective in the treatment of nonalcoholic steatohepatitis (NASH), particularly in combination with other pharmacological agents. UDCA reportedly counteracts the effects...
14.
Wang J, Aihara Y, Kinoshita M, Mamiya J, Priimagi A, Shishido A
Sci Rep
. 2015 May;
5:9890.
PMID: 25944052
Nonlinear optics deals with phenomena where "light controls light"; e.g., there is mediation by an intensity-dependent medium through which light propagates. This field has attracted much attention for its immense...
15.
Fukuba R, Kawaratani H, Kubo T, Kaya D, Aihara Y, Morioka C, et al.
Nihon Shokakibyo Gakkai Zasshi
. 2014 Dec;
111(12):2337-45.
PMID: 25482910
A woman in her 70s with fever and abdominal distension was referred to our hospital for investigation. She had just finished a course of pegylated interferon and ribavirin combination therapy...
16.
Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, et al.
Mol Med Rep
. 2014 Nov;
11(3):1693-700.
PMID: 25421042
Previous clinical studies have demonstrated that endotoxin/toll‑like receptor 4 (TLR4) signaling is critical in the inflammatory pathways associated with non‑alcoholic steatohepatitis (NASH). In human and animal studies, NASH was associated...
17.
Yoshiji H, Noguchi R, Namisaki T, Moriya K, Kitade M, Aihara Y, et al.
J Gastroenterol
. 2013 Nov;
49(10):1421-9.
PMID: 24197250
Background: Given the well-documented adverse side effects of sorafenib, many sorafenib-treated patients may need the reduced initial dose of the compound, and an alternative sorafenib-based therapy, which exerts similar clinical...
18.
Yoshiji H, Noguchi R, Namisaki T, Moriya K, Kitade M, Aihara Y, et al.
Oncol Rep
. 2013 May;
30(2):545-52.
PMID: 23708326
Branched-chain amino acids (BCAAs) reportedly inhibit the incidence of hepatocellular carcinoma (HCC) in patients with liver cirrhosis and obesity that is frequently associated with insulin resistance (IR). We previously reported...
19.
Kaji K, Yoshiji H, Ikenaka Y, Noguchi R, Aihara Y, Douhara A, et al.
J Gastroenterol
. 2013 Mar;
49(3):481-91.
PMID: 23475323
Background: Dipeptidyl peptidase-4 inhibitor (DPP4-I) is clinically used as a new oral antidiabetic agent. Although DPP4 is reportedly associated with the progression of chronic liver diseases, the effect of DPP4-I...
20.
Aihara Y, Yoshiji H, Noguchi R, Kaji K, Namisaki T, Shirai Y, et al.
Hepatol Res
. 2013 Mar;
43(11):1241-50.
PMID: 23448275
Aim: Renin is a rate-limiting enzyme of the renin-angiotensin system (RAS), and several reports have shown that renin plays an important role in several pathological processes. Although RAS is known...